|
|
|
The Biomedical & Life Sciences
Collection
This Month's Releases
|
|
|
|
|
Non-Mendelian
genetics: the X chromosome
Dr.
Carole Sargent
University of Cambridge, UK
|
|
|
|
|
|
RNA
modifications in human diseases: what, when and how?
Prof. Chengqi Yi
Peking University, China
|
|
|
|
|
|
The
blood-brain barrier in Alzheimer's disease
Dr.
Anika Hartz
University of Kentucky, USA
|
|
|
|
|
|
The
potential of CAR T cells for the treatment of autoimmune diseases
Dr.
Marko Radic
University of Tennessee, USA
|
|
|
|
|
|
Lymphoid
architecture - the meeting places that spark the body's immune
reactivity: design and dynamics
Dr.
Simon Hunt
University of Oxford, UK
|
|
|
|
|
|
Virtual
screening
Dr. John
H. Van Drie
Van Drie Research LLC, USA
|
|
|
|
|
|
Stroke-induced
heart injury
Dr.
Luciano A. Sposato
Western University, Canada
|
|
|
|
|
|
The
heart and pericardium
Prof.
Thomas R. Gest
Central Michigan University, USA
|
|
|
|
|
|
Approaches
to nonclinical vaccine development
Dr. Lisa
Plitnick
Merck & Co., Inc., USA
|
|
|
|
|
|
Patent
sufficiency a UK and European perspective
Dr.
Jonathan D.M. Atkinson
Partner HGF Limited and Director, Atkinson IP Consulting Limited, UK
|
|
|
|
|
|
Laboratory
methods for the in vitro study of drug metabolism
Dr. Ritu Singh
Broad Institute of MIT and Harvard, USA
|
|
|
|
|
|
Intracerebral
hemorrhages: causes and clinical findings
Prof.
Louis Caplan
Harvard Medical School, USA
|
|
|
|
|
|
Hypersensitivity
diseases: type 1 hypersensitivity
Prof.
Herman Waldmann
University of Oxford, UK
|
|
|
|
|
|
Neuropathology
of neurodegenerative disorders
Prof.
Jillian Kril
University of Sydney, Australia
|
|
|
|
|
|
How can
molecular chaperones repair damaged protein
structures?
Prof.
Pierre Goloubinoff
Lausanne University, Switzerland
|
|
|
|
|
|
Phase II
trials
Dr.
Patricia Tang
University of Calgary, Canada
|
|
|
|
|
|
Epidemiology
of COPD
Dr.
David Mannino
University of Kentucky, USA
|
|
|
|
|
Interviews
about the Covid-19 pandemic
|
|
|
|
Emergence
of blood clotting disorders resulting from COVID vaccines inoculations
Prof.
Dr. Sabine Eichinger
Medical University of Vienna, Austria
|
|
|
|
|
|
SARS-COV-2
human monoclonal antibody therapy update
Prof.
James Crowe
Vanderbilt Vaccine Center, USA
|
|
|
|
|
|
SARS-CoV-2
evolution: emergence of the 'Californian' and 'Indian' variants
Prof.
Eric Vail
Cedars-Sinai Medical Center, USA
|
|
|
|
|
|
SARS-CoV-2
variants: implications for immunity and vaccine development
Prof.
Danny Altmann
Imperial College London, UK
|
|
|
|
|
Featured
talks from previous releases
|
|
|
|
|
|
For more specially commissioned lectures:
|
